Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference

   Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock
                                  Conference

PR Newswire

QUÉBEC CITY, March 13, 2013

QUÉBEC CITY, March 13, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the "Company") today announced that its President and CEO,
Juergen Engel, PhD, will be presenting a corporate overview at the Roth 25^th
Annual OC Growth Stock Conference on Tuesday, March 19, 2013, at 9:30 am
(Pacific), in Track 6: Salon 5-Pink of the Ritz Carlton hotel in Dana Point,
California.

A live webcast of this slide presentation will be available on Aeterna
Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the
webcast will also be available on the Company's website for a period of 90
days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company
currently investigating treatments for various unmet medical needs. The
Company's pipeline encompasses compounds at all stages of development, from
drug discovery through to marketed products. For more information please visit
www.aezsinc.com.

SOURCE AETERNA ZENTARIS INC.

Contact:

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com

Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com